Aloxi web

Indication

INDICATION

ALOXI^® is indicated for:

the prevention of acute nausea and vomiting associated with initial and repeat courses of moderately and highly emetogenic cancer chemotherapy, and
the prevention of delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.

CONTRAINDICATIONS

ALOXI is contraindicated in patients known to have hypersensitivity to the drug or any of its components.

ADVERSE REACTIONS

The most commonly reported adverse reactions were similar to those seen with other 5-HT₃ receptor antagonists.

Headache (9%)
Constipation (5%)

GENERAL PRECAUTIONS

ALOXI should be administered with caution in patients who have or may develop prolongation of cardiac conduction intervals, particularly QTc.

(See full Precautions section of full Prescribing Information).

During initial and repeat courses of chemotherapy, ALOXI helps prevent and control nausea and vomiting the day following chemotherapy that is highly likely to cause nausea and vomiting, and for up to 5 days following chemotherapy that is likely to cause nausea and vomiting. The most frequent side effects of ALOXI include headache and constipation. If you have or may develop significant heart rhythm changes, talk with your healthcare professional before receiving ALOXI.

ALOXI is available by prescription only. Please see the important product information for ALOXI for more information.

This site does not contain everything that is known about ALOXI. If you would like to know more, talk to your healthcare professional.